Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
11
×
life sciences
national blog main
national top stories
new york top stories
11
×
boston blog main
boston top stories
new york blog main
san francisco top stories
national
san diego blog main
san diego top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas top stories
wisconsin blog main
wisconsin top stories
indiana blog main
indiana top stories
texas blog main
fda
clinical trials
ceo
commissioner
drug development
drug pricing
drugs
europe top stories
gene editing
gene therapy
immunotherapy
ipo
lung cancer
What
medicine
11
×
bio
cancer
drug
fda
new
patients
roundup
friday
goes
help
long
nobel
prize
study
therapy
treatment
adapt
ago
alnylam
alzheimer's
ambitious
approve
approved
ask
atrophy
awaits
bad
big
biological
biopharma
bosley's
bosley’s
brain
bridge
bucks
car
cas
case
celgene
Language
unset
Current search:
medicine
×
biotech
×
" new york top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Ireland to Sequence 400K Genomes With New Precision Medicine Effort
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?